The U.S. Food and Drug Administration has approved Sanofi's Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce ...
Zacks Investment Research on MSN2d
SNY Gets FDA Nod for First Ever Hemophilia Drug in the United StatesSanofi SNY and partner, Alnylam Pharmaceuticals ALNY, announced that the FDA has approved Qfitlia (fitusiran) as the first ...
Introduction The U.S. Food and Drug Administration (FDA) has granted approval for Sanofi’s (NASDAQ:SNY) hemophilia therapy, Qfitlia, marking a significant advancement in treatment options for patients ...
PARIS, France I March 28, 2025 I The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for ...
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today highlighted the significance of the U.S. Food and Drug Administration's (FDA) approval of Qfitliatm (fitusiran), the sixth ...
If you look closely, you’ll see him underneath the Friday night lights during varsity football season at Eastern High School.
About 30% of people hospitalized due to acquired hemophilia have a bleeding event, while 17% have a blood clot-related ...
If you look closely, you’ll see him underneath the Friday night lights during varsity football season at Eastern High School.
AB negative – he was considered a ‘universal donor of platelets’ which meant that anyone could receive his platelets without ...
The Union Health Ministry has launched the e-Blood Bank Portal, making it easier for patients and organisers to access blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback